It's possible that investing in GENR can be a serious waste of time and money for the following reasons:
1.) Low Volume seems to indicate Low investor interest
2.) Big Selection of Many Biotech Stocks can threaten the price of GENR stock due to "strong competition" from other biotech stocks
3.)The Stock Price of GENR does not pass the $1.90+ level for a long time now and is short lived at that level anyway. GENR constantly experiences quick "retreats" and "pullbacks" to the $1.70 level and even lower (in other words, quick profit taking due to low investor confidence)
4.) The product "EVIZON" has a long way to produce any significant revenues, if any.
This stock GENR seems to exhibit a lot of doubt as the Company's Press Releases lack any encouragement as well !
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.